Beneficiaries

Helmholtz Zentrum München (coordinator) Germany (HMGU)

AstraZenenca AB, Sweden (AstraZeneca)

Bayer Aktiengesellschaft, Germany (Bayer)

Pfizer, Germany 

Sanofi-Aventis Recherche & Développement, France (Sanofi)

Molecular Networks Gmbh Computerchemie, Germany (MolNet)

Københavns Universitet, Denmark (UCPH)

Université de Strasbourg, France (UNISTRA)

Universiteit Leiden, Netherlands (ULEI)

Istituto di Ricerche Farmacologiche Mario Negri, Italy (IRFMN)

Center for Genomic Regulation, Spain (CRG)

Technische Universität München, Germany (TUM)

Technische Universiteit Eindhoven, Netherlands (TU/e)

École Normale Supérieure, France (ENS-PSL)

Associated Partners

Università Della Svizzera Italiana, Switzerland (USI)

Ecole Polytechnique Fédérale De Lausanne, Switzerland (EPFL)

Universitat De Barcelona, Spain (UB)

Ascenion GmbH, Germany (Ascenion)

Chelonia SA, Switzerland (Chelonia)

US Food & Drug Administration, United States (FDA)

Interagency Center for the Evaluation of Alternative Toxicological Methods, United States (NIEHS/NIH)

CEHTRA SAS, France (CEHTRA)

Korea Institute of Toxicology, South Korea (KIT)

Syngenta Crop Protection

European Chemicals Agency, Finland (ECHA)